Drugs / US-Herceptin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03776240 Comparator | Apr → Aug 2019 | — | Prestige Biopharma Limited | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | US-Herceptin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03776240 ↗ |
| Route | Intravenous | “Single-dose 6mg/kg body weight by 90 minute intravenous infusion” NCT03776240 ↗ |